| |
| |
|
| Insider
Information: |
Ragosa Mark |
| Relationship: |
|
| City: |
Hamilton |
| State: |
D0 |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
22,958 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$553,288 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
22,958 |
|
|
| Total
Value |
$553,288 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Kiniksa Pharmaceuticals, Ltd. |
KNSA |
|
2024-09-02 |
22,958 |
2020-12-31 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
36 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHIEF FINANCIAL OFFICER |
• – – |
2024-04-01 |
4 |
D |
$19.70 |
$10,126 |
D/D |
(514) |
16,868 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHIEF FINANCIAL OFFICER |
• – – |
2024-04-08 |
4 |
D |
$17.90 |
$14,159 |
D/D |
(791) |
18,771 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHIEF FINANCIAL OFFICER |
• – – |
2024-04-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,694 |
19,562 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHIEF FINANCIAL OFFICER |
• – – |
2024-04-26 |
4 |
OE |
$0.00 |
$0 |
D/D |
991 |
19,762 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHIEF FINANCIAL OFFICER |
• – – |
2024-04-26 |
4 |
D |
$17.88 |
$9,101 |
D/D |
(509) |
19,253 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHIEF FINANCIAL OFFICER |
• – – |
2024-07-23 |
4 |
OE |
$11.10 |
$269,153 |
D/D |
24,248 |
43,501 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHIEF FINANCIAL OFFICER |
• – – |
2024-07-23 |
4 |
AS |
$24.79 |
$601,108 |
D/D |
(24,248) |
19,253 |
0 |
% |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHIEF FINANCIAL OFFICER |
• – – |
2024-09-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,444 |
24,313 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHIEF FINANCIAL OFFICER |
• – – |
2024-09-01 |
4 |
D |
$26.74 |
$60,432 |
D/D |
(2,260) |
22,053 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHIEF FINANCIAL OFFICER |
• – – |
2024-09-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,861 |
23,914 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHIEF FINANCIAL OFFICER |
• – – |
2024-09-02 |
4 |
D |
$26.74 |
$25,563 |
D/D |
(956) |
22,958 |
0 |
- |
|
36 Records found
|
|
Page 2 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
